Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE : Further evidence for survival and safety and implications for early treatmentVINCENT, Jean-Louis; BERNARD, Gordon R; WONG, Kar et al.Critical care medicine. 2005, Vol 33, Num 10, pp 2266-2277, issn 0090-3493, 12 p.Article

Effects of drotrecogin alfa (activated) in human endotoxemiaKALIL, Andre C; COYLE, Susette M; UM, John Y et al.Shock (Augusta, Ga.). 2004, Vol 21, Num 3, pp 222-229, issn 1073-2322, 8 p.Article